 PET Facility Registration
Facility Login
Home
What Is The NOPR 
NOPR Forms
Info For PET Facilities
Info For Referring 
Physicians
Work Flow Timeline
Indications (FDG only)
HIPAA, IRB, etc.
HITECH Amendment
Referring Physician Letter
Physician Information sheet
Operations Manual
Introduction
Section A: NOPR-2009
Section B: NOPR(NaF-PET)
Combined Operations Manual
Info For Patients 
Frequently Asked
Questions
Educational Materials
Publications
News
Monthly Status Report
Contact Us
|
 |
| |
NOPR Objective
The goal of the National Oncologic PET Registry (NOPR) since it began operation in 2006 has been to assess the effect of positron emission
tomography (PET) with F-18 fluorodeoxyglucose (FDG) on referring physicians’ plans of intended patient management for those cancers and
indications not currently eligible for reimbursement from the Centers for Medicare & Medicaid Services (CMS).
Since the April 2009 expansion in CMS coverage for FDG-PET, the NOPR has continued to collect similar data for many remaining cancer indications
for FDG-PET (NOPR 2009). Additionally, beginning in 2011, based on a February 2010 National Coverage Decision, the NOPR also is collecting data
on referring physicians’ plans of intended patient management for Medicare patients undergoing PET with sodium fluoride-18 (NaF-PET) for
evaluation of proven or strongly suspected bony metastatic disease [(NOPR (NaF-PET)].
Data will be collected from the referring physician before and after the PET study. If complete
and timely data are reported to the NOPR within 30 days of the PET scan, the PET facility and interpreting physician (nuclear physician/radiologist)
will be eligible for reimbursement by CMS.
Collection of the information required by the NOPR is a condition for reimbursement of the PET scan by the Medicare program for eligible patients. (CMS has designated this mechanism for reimbursement as “coverage with evidence development.”) Such patients would otherwise be required to pay for the PET study themselves, or would not have PET performed at all.
PET Facility Participants
Any PET facility that is approved to bill CMS for either technical or global charges can apply to participate in the NOPR. PET facilities are charged a one time $50 facility registration fee and $50 for each patient entered on the Registry. There is no charge to referring physicians or to patients for registry participation. There is no payment to referring physicians from completion of the required Pre-PET and Post-PET forms.
Patient Eligibility
Medicare beneficiaries who are referred for PET for essentially all oncologic indications that are not currently reimbursable
under Medicare (see Indications table for specific coverage and exclusions) are eligible to
participate in the NOPR. Medicare beneficiaries who are referred for NaF-PET for evaluation of bony metastatic disease also are eligible to participate in the NOPR.
Referring Physician's Responsibilities
The patient's referring physician must agree to complete Pre- and Post-PET data collection forms that include questions regarding
the patient’s planned management.
- The Pre-PET Form must be completed and signed by the referring physician and returned to the PET facility prior to the patient’s PET scan.
Blank Pre-PET Forms for FDG-PET or NaF-PET can be downloaded from the NOPR Web site and sent to the PET facility at the time of patient referral. If the form is not submitted with the referral, a patient-specific form can be obtained from the PET facility.
The Pre-PET Form can be returned to the PET facility via FAX, mail, or hand delivery.
- After the PET scan is performed, a patient-specific Post-PET Form for either FDG-PET
or NaF-PET will be sent to the referring physician for completion
within 30 days. This form can also be returned to the PET facility via FAX, mail, or hand delivery.
The case is eligible for CMS reimbursement only if the Pre-PET Form is completed and returned to the PET facility prior to the PET scan and the Post-PET Form is completed and returned within 30 days of the PET scan.
|
|
|
